David has broad experience spanning the drug discovery and development process from his roles as scientist and consultant in biotech startups, consulting, contract research at AMRI Global and GMP manufacturing at GSK. Most recently, he worked on process development and manufacturing strategies to supply material for preclinical and first-in-human studies, including cell and gene therapies. He holds a PhD in Organic Chemistry from the Australian National University and a Bachelor of Technology (Hons) in Chemical Technology from Massey University, New Zealand.